Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Brister Mark
Chief Technology Officer
Transactions
- Award
Common Stock (Restricted Stock Award)
[F1]2018-01-02+65,000→ 65,000 total
Footnotes (1)
- [F1]The Restricted Shares shall vest as to one-half of the Shares underlying the Award on each of the first and second anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.
Signature
/s/ Nooshin Hussainy as attorney-in-fact for Mark Brister|2018-01-04